Prothena Corp Public (PRTA) Capital Expenditures (2012 - 2025)
Prothena Corp Public (PRTA) recorded quarterly Capital Expenditures of $10000.0 in Q3 2025, down 88.37% quarter-over-quarter from $86000.0 in Q2 2025, and up 11.11% on a YoY basis from $9000.0 in Q3 2024.
Prothena Corp Public (PRTA) Capital Expenditures (2012 - 2025) Analysis & Trends
Prothena Corp Public's Capital Expenditures history runs 14 years deep, the most recent figure standing at $10000.0 for Q3 2025.
- In Q3 2025, Capital Expenditures rose 11.11% year-over-year to $10000.0; the TTM figure through Mar 2026 stood at $96000.0 (down 59.49% YoY), while the FY2025 annual figure was $138000.0, down 53.69% from the prior year.
- Capital Expenditures was $10000.0 for Q3 2025 at Prothena Corp Public, down from $86000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $1.5 million in Q4 2023 to a low of $9000.0 in Q3 2024.
- Historically, Capital Expenditures has averaged $238055.6 across 5 years, with a median of $116500.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures surged 925.83% in 2023, then sank 97.96% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $319000.0 in 2021, then sank by 52.66% to $151000.0 in 2022, then soared by 925.83% to $1.5 million in 2023, then slumped by 97.22% to $43000.0 in 2024, then slumped by 76.74% to $10000.0 in 2025.
- The last three Capital Expenditures figures came in at $10000.0 (Q3 2025), $86000.0 (Q2 2025), and $42000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 10,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 86,000.00 |
| Jun 30, 2025 | 86,000.00 |
| Mar 31, 2025 | 42,000.00 |
| Mar 31, 2025 | 42,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 143,000.00 |
| Mar 31, 2024 | 103,000.00 |
| Mar 31, 2024 | 103,000.00 |
| Dec 31, 2023 | 1.55 Mn |
| Dec 31, 2023 | 1.55 Mn |
| Sep 30, 2023 | 442,000.00 |
| Sep 30, 2023 | 442,000.00 |
| Jun 30, 2023 | 771,000.00 |
| Jun 30, 2023 | 771,000.00 |